3Q2015 - Presentation of results 1
-
Highlights 3Q2015
-
Operational Development
-
Performance by business area
-
Financial debt
- Annexes
3Q2015 - Presentation of results 2
Highlights 3Q2015
CORPORATE BUSINESS |
Sale of Testa 77% delivered as of sept 2015 (25% 1Q/15 + 52% 3Q/15)
|
Reduction of the financial debt
|
IMPROVEMENT OF STRATEGIC GROWTH |
Sacyr Industrial Sacyr Fluor incorporation Sacyr Nervión incorporation |
Concessions + Construction Awards in strategic geographical areas and businesses: Colombia, Mexico, Uruguay (November) |
OPERATIONAL DEVELOPMENT |
Consolidation of growth in all business lines Revenue + 15% |
Profitability of core businesses Ebitda margin 11,6% |
3Q2015 - Presentation of results 3
Operational Development
€ million | SEPT 15 | SEPT 14* | Chg 15/14 |
REVENUE | 2,123 | 1,842 | 15% |
EBITDA | 247 | 163 | 51% |
EBITDA margin | 11.6% | 8.8% | +2.8 pp |
EBIT | 134 | 114 | 18% |
NET PROFIT | 532 | 83 | - |
BACKLOG | 31,231 | 28,616 (Dec. 14) | +9% |
CORPORATE NET DEBT (Includes debt associated with Itinere) | 91 | 540 (Dec. 14) | -83% |
* Adjusted with TESTA accounted for as discontinued operation.
3Q2015 - Presentation of results 4
distributed by |